Pivmecillinam Hydrochloride

7 trials 5 recruiting JAnti-infectives

Filter these 7 trials by condition, phase, country and more.

Open in Search →

7 Registered trials

5 Recruiting

0 Completed trials

7 Sponsors

5 Countries

Phase III

Phase II

Phase IV

Phase III: 2 Phase II: 1 Phase IV: 4

Indications tested

Spinal cord injury 1

Sponsors using this IMP

Centre Hospitalier Universitaire De Nantes 1 Inmunotek S.L. 1 Odense University Hospital 1 Region Hovedstaden 1 Region Skane 1 Rigshospitalet 1 Uppsala Universitet 1

All trials

7 total

ANTIBIOBONTA - Assessment of the interest of a peri-operative antibiotic strategy applied to patients with asymptomatic bacteriuria undergoi… Pending

2024-515107-19-00 Phase III 1 country Centre Hospitalier Universitaire De Lille
Trial to confirm efficacy, safety, and clinical impact between the bacterial mucosal immunotherapy compared with placebo in women with local… Pending

2025-524377-16-00 Phase III 1 country Inmunotek S.L.
TRI-AB trial Recruiting

2024-520251-24-00 Phase IV 1 country Odense University Hospital
Pivmecillinam as oral step-down treatment for Escherichia coli febrile urinary tract infection versus standard of care; a randomized control… Recruiting

2023-503447-33-00 Phase II 2 countries Uppsala Universitet
REINFORCE – Reducing infection-related readmissions following cystectomy. Recruiting

2024-514312-27-00 Phase IV 1 country Rigshospitalet
Short course antibiotic treatment of Gram-negative bacteremia: A multicenter, randomized, non-blinded, non-inferiority interventional study Recruiting

2024-514900-16-00 Phase IV 1 country Region Hovedstaden
Alternative antibiotics to multidrug-resistant UTIs Recruiting

2024-513294-41-00 Phase IV 1 country Region Skane

Showing 1–7 of 7 trials

← All drugs A–Z